Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,223 | -38,704 | -30,007 | -21,436 | -10,993 |
| Depreciation Amortization | -73 | 868 | 822 | 626 | 377 |
| Accounts receivable | 95 | -236 | -115 | -16 | 88 |
| Other Working Capital | 1,573 | -380 | 1,372 | 1,520 | -924 |
| Other Operating Activity | 969 | 4,632 | 3,498 | 2,362 | 1,203 |
| Operating Cash Flow | $-8,659 | $-33,820 | $-24,430 | $-16,944 | $-10,249 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,337 | 39,041 | 31,946 | 26,378 | 18,529 |
| PPE Investments | -8 | -1,006 | -931 | -483 | -171 |
| Other Investing Activity | 0 | 114 | 114 | 71 | 0 |
| Investing Cash Flow | $7,329 | $38,149 | $31,129 | $25,966 | $18,358 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 75 | 75 | N/A | N/A |
| Financing Cash Flow | $N/A | $75 | $75 | $N/A | $N/A |
| Beginning Cash Position | 16,347 | 11,943 | 11,943 | 11,943 | 11,943 |
| End Cash Position | 15,017 | 16,347 | 18,717 | 20,965 | 20,052 |
| Net Cash Flow | $-1,330 | $4,404 | $6,774 | $9,022 | $8,109 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,659 | -33,820 | -24,430 | -16,944 | -10,249 |
| Capital Expenditure | -8 | -1,006 | -931 | -483 | -171 |
| Free Cash Flow | -8,667 | -34,826 | -25,361 | -17,427 | -10,420 |